The Commission report pointed out that medicinal products containing ephedrine and pseudoephedrine were diverted into the illicit drug manufacture outside the Union, as a substitute for internationally controlled ephedrine and pseudoephedrine. The Commission therefore recommended strengthening the control of international trade in medicinal products containing ephedrine or pseudoephedrine exported from or transiting through the customs territory of the Union in order to prevent their diversion for the illicit manufacture of narcotic drugs or psychotropic substances.
Recital 3, Regulation (EU) No 1259/2013 of the European Parliament and of the Council of 20 Novembe…
In forcesince 20 Nov 2013cited 1×
Judgment of the Court (Fifth Chamber) of 5 February 2015. Miguel M. and Others.Decision
The definition of ‘scheduled substance’ in Articles 2(a) of Regulations Nos 273/2004 and 111/2005 was amended by Regulation (EU) No 1258/2013 of the European Parliament and of the Council of 20 November 2013 (OJ 2013 L 330, p. 21) and …
5 Feb 2015 · 62013CJ0627